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Introduction
Although indiscriminate use of broad-spectrum antibiotics
is related to the occurrence of bacterial resistance, there is
an abusive use of such drugs.
Objectives
To determine the antimicrobial usage in the treatment of
patients with bloodstream infection (BSI) caused by methi-
cillin-resistant and susceptible Staphylococcus aureus
(MRSA and MSSA, respectively).
Methods
Retrospective cohort study performed in an Intensive Care
Unit of a large hospital in Belo Horizonte. The population
is comprised of patients diagnosed with Staphylococcus
aureus BSI from 2007 to 2011. Data were obtained
through patients’ medical records and Hospital Infection
Control Committee. Therapy were categorized in: empiri-
cal treatment (before the culture test result) or directed
(according to the BSI causing agent). Descriptive and uni-
variate analysis were performed (using chi-square test or a
Fisher’s exact test). The hospital’s Ethics Committee
approved the project.
Results
62 patients were included, 31 in each group (MRSA and
MSSA). The most common antibiotics prescribed for
empirical treatment were vancomycin (69.4%), polymyxin
B (46.8%), ertapenem (29.0%), meropenem (24.2%) and
cefepime (3.2%). There was no significant difference
between the groups analyzed and the class of antimicro-
bials empirically prescribed (p>0.05). For directed treat-
ment, the antibiotics prescribed were vancomycin (45.2%)
and methicillin (40.3%). On one hand, MRSA group used
significantly more vancomycin (p=0,000). On the other
hand, MSSA patients used more methicillin after the cul-
ture result (p=0,000).
Conclusion
A large use of broad-spectrum antibiotics in empirical
treatments was observed, given the hospital’s microbiolo-
gical profile and the need to initiate appropriate treatment
during the first 24 hours. However, the treatment targeting
favored a rational use of antibiotics, reducing the action
spectrum after culture results.
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